Medication-Assisted Treatment (MAT) Centers in Missouri

No. Missouri MAT providers do not require criminal-history disclosure to enroll. Federal law (42 CFR Part 2) protects substance-use treatment records; a criminal record will not block admission to a mat program.

It depends on the program. Bundled MAT programs include counseling in a single weekly or monthly fee. Others bill counseling separately ($40–$150 per session). MO HealthNet and most commercial plans cover both components when delivered by a licensed provider.

Yes. MO HealthNet covers the medication (methadone, buprenorphine, or naltrexone), counseling sessions, group therapy, drug screening, and care coordination as an integrated MAT benefit. Peer-recovery support is also reimbursable in Missouri under the state plan.

Yes. Missouri commercial plans cover Sublocade under the medical benefit (administered in clinic) with prior authorization documenting adherence to sublingual buprenorphine. The mat provider’s office handles the PA paperwork.

Yes. mat is a federally approved medication used legally across Missouri. Methadone is dispensed only at SAMHSA-certified Opioid Treatment Programs (OTPs); buprenorphine is prescribed by licensed clinicians; naltrexone has no prescriber waiver requirement. State licensing agencies oversee all MAT programs.

Tapering happens under medical supervision over weeks to months — usually slower for methadone, faster for buprenorphine. Your Missouri provider will monitor withdrawal symptoms and cravings, and resume MAT immediately if cravings return. Never taper without clinical oversight.

Yes. Buprenorphine induction and follow-up are routinely delivered by telehealth in Missouri under permanent federal rules. Naltrexone can be prescribed via telehealth too. Methadone induction requires an in-person OTP visit for the first dose.

Expect questions about your substance use history, overdose history, medical and mental-health conditions, current medications, pregnancy risk, social support, housing, legal status, and treatment goals. Answers help tailor the plan — honesty produces better clinical care, and answers are protected under 42 CFR Part 2.

During induction (first 1–2 weeks), mild drowsiness is common. Once stabilized, most patients fully resume work, including safety-sensitive jobs such as CDL driving, subject to any employer drug-testing policies. Missouri clinicians can issue letters documenting stability.

Naltrexone is typically not started during pregnancy due to limited safety data — methadone or buprenorphine are preferred. Patients already stable on naltrexone who become pregnant discuss continuing versus switching with their Missouri MAT provider and obstetrician.

Common options include cognitive-behavioral therapy, motivational interviewing, contingency management, group counseling, and trauma-focused therapy. Many Missouri programs also offer peer-recovery support. The clinical team matches you with the modality most aligned to your goals.

Yes. Your records are protected by federal law 42 CFR Part 2, which is stricter than HIPAA. Disclosure requires your signed consent or a specific court order; even law enforcement cannot access records without one of these.